Loading...

Ascendis Pharma A/S

ASNDNASDAQ
Healthcare
Biotechnology
$167.47
$-0.84(-0.50%)

Ascendis Pharma A/S (ASND) Stock Overview

Explore Ascendis Pharma A/S’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 77.5/100

Key Financials

Market Cap10.1B
P/E Ratio-25.22
EPS (TTM)$-6.82
ROE1.91%
Fundamental Analysis

AI Price Forecasts

1 Week$189.17
1 Month$178.54
3 Months$146.48
1 Year Target$184.73

ASND Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Ascendis Pharma A/S (ASND) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 44.57, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $184.73.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -25.22 and a market capitalization of 10.1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;